G-BA

Fuatilia

G-BA approves four Long Covid drugs for insurance coverage

Germany's Gemeinsamer Bundesausschuss (G-BA) decided on Thursday to allow health insurers to cover four drugs that alleviate certain Long Covid symptoms. Previously, patients had to pay for these off-label uses themselves. The ruling eases access for the country's 74 million statutory insurees.

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa